Cerba Healthcare
Cerba Healthcare, headquartered in France, is a leading player in the global healthcare sector, specialising in laboratory services and diagnostics. Founded in 1967, the company has expanded its operations across Europe, Africa, and the Middle East, establishing a strong presence in the medical testing industry. With a commitment to innovation, Cerba Healthcare offers a comprehensive range of services, including clinical pathology, genetic testing, and specialised diagnostics. Their unique approach combines advanced technology with a patient-centric focus, ensuring high-quality results and rapid turnaround times. Recognised for its excellence, Cerba Healthcare has achieved significant milestones, positioning itself as a trusted partner for healthcare professionals and institutions. The company’s dedication to precision and reliability has solidified its reputation as a leader in the laboratory services market.
DitchCarbon Score
How does Cerba Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cerba Healthcare's score of 14 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cerba Healthcare's reported carbon emissions
In 2023, Cerba Healthcare reported total carbon emissions of approximately 339,011,000 kg CO2e. This figure includes 12,879,000 kg CO2e from Scope 1 emissions, 6,131,000 kg CO2e from Scope 2 emissions, and a significant 320,000,000 kg CO2e from Scope 3 emissions, which primarily stem from purchased goods and services, upstream transportation, and waste generated in operations. Cerba Healthcare has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2022 as the baseline year. Additionally, the company plans to cut its Scope 3 emissions from purchased goods and services by 25% within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to global efforts to limit temperature rise to 1.5°C. The company's emissions data reflects a proactive approach to sustainability within the healthcare sector, highlighting its commitment to reducing its carbon footprint and addressing climate change effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 7,730,000 | - | 00,000,000 |
| Scope 2 | 4,091,000 | - | 0,000,000 |
| Scope 3 | 677,284,000 | - | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cerba Healthcare is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
